Sponsored by Med-Results
Plasma in aesthetics is nothing new, but the popularity of the term ‘plasma’ has led to indiscriminate use, creating confusion for some aesthetic practitioners and patients alike. According to Arash Kalantari, chief executive officer (CEO) and founder of Med-Results (Los Angeles, Calif.), many low-power electrosurgical devices were labeled ‘plasma’ despite not being true plasma generators, until PLEXR.
“After nearly three decades in the medical aesthetics industry, we are witnessing significant evolution in the field,” explained Mr. Kalantari, who is also a medical technologist and inventor. “PLEXR stands out as a pioneer in this evolution, prioritizing a more respectful approach to treating the body. Unlike aggressive t
echnologies that rely on burning and vaporizing the skin, PLEXR adopts a Nano Sublimation modality, marking a groundbreaking shift towards gentler treatments.”
PLEXR transforms atmospheric nitrogen from a gas state to a plasma state to sublimate skin with minimal thermal damage on a nano, micro or standard scale, enhancing skin vitality and health by activating normal skin remodeling properties. Treatments require no numbing for nano-ablative treatments and only topical anesthesia for semi-ablative and ablative protocols.
“When doctors ask me about the best technology to add to their practice, I ask them to identify the most requested treatments they currently cannot provide,” Mr. Kalantari shared. “The most common replies I hear are neck lifts, puff y eyes, smoker’s lines, melasma, acne scars and similar cosmetic concerns. PLEXR can effectively address all of these in just one or two sessions.”
Christopher Croley, MD, owner of Skin & Tonic in Pace, Fla., and a leader in advanced aesthetic medicine, commonly uses PLEXR in his practice. “This device is one of the most popular in my practice due to results seen on patients of all skin types,” he reported. “It is also a highly used device because treatments can be nonablative, or they can be more aggressive for a more profound skin tightening eff ect.”
According to Dr. Croley, plasma energy treatments with PLEXR do not cause thermal damage to surrounding tissue, which is sometimes a concern with other energy-based devices. He clarifi ed that by sublimating tissue, it turns from a solid to a gaseous state, allowing him to remove tissue without thermal damage, resulting in tissue/skin tightening and lifting.
“By using PLEXR for soft surgery, tissue is removed by sublimation using plasma energy and no incisions are necessary,” Dr. Croley explained. “No sutures are required and there is minimal risk of scarring. For soft surgery, topical anesthesia is all that is required. Tissue is removed using specifi c unique protocols creating vectors that ultimately will tighten and lift.”
PLEXR has over 100 indications and can be used in a non-ablative mode to enhance transdermal delivery of drugs and topicals such as hyaluronic acid. In addition to sublimation of tissue, the action of PLEXR can promote collagen and elastin production. “In a semi-ablative or ablative mode, we can actually remove excess tissue, such as upper lid redundant skin and provide more profound collagen stimulation,” Dr. Croley shared. He added that the PLEXR device has a relatively low capital investment cost and more importantly a very low consumable price.
